BJ

Beijing Jilianjiyong Venture Capital

Asia, Beijing, China, Beijing

Description

An Investment Firm.

Investor Profile

Beijing Jilianjiyong Venture Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Pharmaceutical.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Beijing Jilianjiyong Venture Capital frequently co-invest with?

China Life Private Equity Investment
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
Sherpa Capital Entidad Gestora
Europe, Madrid, Spain, Madrid
Co-Investments: 1

What are some of recent deals done by Beijing Jilianjiyong Venture Capital?

Yingke Biopharmaceutical

Taizhou, Jiangsu, China

Yingke Biopharmaceutical operates as a high-tech biopharmaceutical enterprise integrating R&D, production and sales.

BiopharmaPharmaceutical
Series BJun 1, 2023
Amount Raised: $42,286,278